Form 4: QNB Corp Executive Jeffrey Lehocky Increases Stake in Company
SEC Form 4
EVP and CFO Jeffrey Lehocky reports purchasing additional shares of QNB Corp, increasing his direct holdings.
Summary
- Jeffrey Lehocky, EVP and Chief Financial Officer of QNB Corp, has reported several transactions involving the company's common stock.
- On February 21, 2025, Lehocky purchased 1,100 shares at $34.10 and 400 shares at $35.00.
- On February 25, 2025, he acquired an additional 1,500 shares at $35.00.
- Following these transactions, Lehocky directly owns 3,998 shares of QNB Corp common stock.
- Lehocky also holds rights to buy various amounts of common stock at exercise prices of $23.40, $29.51 and $33.50, with expiration dates in 2033, 2034 and 2035.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchases indicate confidence, but it's a routine transaction.
Positives
- Executive's purchase of company stock may signal confidence in the company's future performance.
Industry Context
Executive stock purchases are often viewed positively by the market, as they can indicate management's confidence in the company's prospects. This is a routine disclosure related to insider trading.
Stakeholder Impact
- The increased stake of a key executive could positively influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/15/2024 | Date exercisable for Common Stock(Right to Buy) at $29.51 expiring 02/15/2033 |
| 02/21/2025 | Purchase of 1,100 shares of common stock at $34.10 per share. |
| 02/21/2025 | Purchase of 400 shares of common stock at $35.00 per share. |
| 02/25/2025 | Purchase of 1,500 shares of common stock at $35.00 per share. |
| 02/14/2026 | Date exercisable for Common Stock(Right to Buy) at $33.50 expiring 02/14/2035 |
| 02/15/2025 | Date exercisable for Common Stock(Right to Buy) at $29.51 expiring 02/15/2033 |
| 02/15/2025 | Date exercisable for Common Stock(Right to Buy) at $23.4 expiring 02/15/2034 |
| 02/14/2027 | Date exercisable for Common Stock(Right to Buy) at $33.50 expiring 02/14/2035 |
| 02/15/2026 | Date exercisable for Common Stock(Right to Buy) at $29.51 expiring 02/15/2033 |
| 02/15/2026 | Date exercisable for Common Stock(Right to Buy) at $23.4 expiring 02/15/2034 |
| 02/14/2028 | Date exercisable for Common Stock(Right to Buy) at $33.50 expiring 02/14/2035 |
| 02/15/2027 | Date exercisable for Common Stock(Right to Buy) at $29.51 expiring 02/15/2033 |
| 02/15/2027 | Date exercisable for Common Stock(Right to Buy) at $23.4 expiring 02/15/2034 |
| 02/14/2029 | Date exercisable for Common Stock(Right to Buy) at $33.50 expiring 02/14/2035 |
| 02/15/2028 | Date exercisable for Common Stock(Right to Buy) at $29.51 expiring 02/15/2033 |
| 02/15/2028 | Date exercisable for Common Stock(Right to Buy) at $23.4 expiring 02/15/2034 |
| 02/14/2030 | Date exercisable for Common Stock(Right to Buy) at $33.50 expiring 02/14/2035 |
| 02/15/2029 | Date exercisable for Common Stock(Right to Buy) at $23.4 expiring 02/15/2034 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.